J Neural Transm (Vienna)

1. POPLAWSKA-DOMASZEWICZ K, Kaasinen V, van der Plas AA, Barbosa PM, et al
   Management of neuropsychiatric, motor and non-motor symptoms in Parkinson s disease after long distance air travel: a consensus view.
   J Neural Transm (Vienna). 2025 Sep 23. doi: 10.1007/s00702-025-02982.
   

   >> Share

   
   

   
   J Neurol Neurosurg Psychiatry

2. JI Q, Chen Z, Ma Y, Guan Q, et al
   Global burden of early-onset Parkinson's disease, 1990-2021: results from the Global Burden of Disease Study 2021.
   J Neurol Neurosurg Psychiatry. 2025 Sep 18:jnnp-2024-335535.
   

   >> Share

   
   

   
   Mov Disord

3. FAN Y, Hu Z, Yan QQ, Wan JJ, et al
   Reply to "Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals".
   Mov Disord. 2025 Sep 24. doi: 10.1002/mds.70060.
   

   >> Share

   
   
4. MARTIN-BORNEZ M, Shar N, Nour MA, Murphy D, et al
   Does COMT Play a Role in Parkinson's Disease Susceptibility across Diverse Ancestral Populations?
   Mov Disord. 2025 Sep 23. doi: 10.1002/mds.70040.
   

   >> Share

   
   

   
   Neurology

5. PERSICO M, Esper CD
   Can Intrinsic Capacity Help Identify Those at Risk of Parkinson Disease?
   Neurology. 2025;105:e214242.
   

   >> Share

   
   
6. HU W, Tian G, Wang JN, Ma YB, et al
   Intrinsic Capacity Defined Using 4 Domains, Genetic Risk, and Incident Parkinson Disease: A Prospective Cohort Study.
   Neurology. 2025;105:e214144.
   

   >> Share

   
   

   
   Neuroscience

7. MADHUSUDHAN K, Padmanaban A, Parvathi VD
   Early detection of Parkinson's disease via aptamer-CRISPR platform.
   Neuroscience. 2025 Sep 20:S0306-4522(25)00951.
   

   >> Share

   
   
8. BAO W, Ge Y, Huang J, Li Y, et al
   DJ-1/PARK7 in Parkinson's disease: mechanisms of pathogenesis and therapeutic potential.
   Neuroscience. 2025 Sep 19:S0306-4522(25)00949.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share